Leaders Pursue New Approaches to Active Ageing Across the Life Course Through Skin Health, Age-Friendly Cities and Innovation

2015 Shenyang Active Ageing Summit Convenes Cross-Sector Stakeholders to Advance Partnerships to Enable Ageing Populations in China and Across the Globe

SHENYANG, P.R. CHINA (22 July 2015) – Today cross-sector industry leaders, government officials and international experts in ageing, dermatology, public policy, and business have come together to affirm the need for further action and awareness around the social and economic importance of healthy and active ageing across the life course as well as the essential role that healthy skin plays in that process.

The 2015 Shenyang Active Ageing Summit brings together leaders for the purpose of collaboration through multi-faceted discussions centered on skin health as a path to active ageing and age-friendly best practices across China and globally. It follows the momentum and actionable outcomes identified at the Manchester Summit on Healthy Skin and Active Ageing in England in June of 2014. The Manchester Summit resulted in the creation of the “Life Course of Healthy Skin Global Partnership,” a commitment to increasing collaboration, awareness, research and innovation in skin health as a central strategy on the global active ageing agenda.

“As increased longevity extends lives into our 70s, 80s, 90s and even 100s, conditions that are associated with old age are becoming more prevalent,” said Michael W. Hodin, CEO of the Global Coalition on Aging. “However, ageing need not be seen as a burden if we take the appropriate actions. Twenty-first century demographic shifts demand a reimagined approach to the process of ageing – one that is active and includes paying close attention to the essential role of healthy skin throughout the life course. This shift in approach also presents an opportunity for reduced healthcare costs and a path to economic growth.”

With China’s 65-plus population skyrocketing from 12 percent in 2010 to over one-third of its total population by 2050 and increasing demand for healthcare in China driven by this demographic shift, rapid urbanization, and industrial development, China finds itself at the center of the global dialogue. Further, as environment plays an essential role in how well one is able to age, cities with infrastructure and policies that drive age-friendly initiatives are growing in demand as a means for active ageing and ultimately economic sustainability.

The two-day Shenyang Summit is hosted by the Global Coalition on Aging, China Medical University, and Shenyang City Government. Summit partners include Renmin University of China, Neusoft, and Nestlé Skin Health.

“We are delighted to welcome leaders from around the world to Shenyang, China to discuss such an important and consequential topic for our country and its future,” said Professor Xing-Hua Gao, Deputy President of the No.1 Hospital of China Medical University. “China’s demographic landscape presents the opportunity for forward-thinking policy and international collaboration that will result in China serving as a model for healthy and active ageing.”

Shenyang, the capital city of Liaoning Province, is a city steeped in history of over 2,000 years tracing back to Warring States Period and is known as an industrial center and transportation hub for China’s northeast. Shenyang has a population of about 10 million with 6 million in urban areas and currently 21 percent of its population over 60 years old.

“Leaders across academia and government in China are advancing support for our ageing populations through age-friendly cities, taking into consideration policy and infrastructure modifications that promote the overall wellness of society,” said Professor Peng Du, Director of the Institute of Gerontology, Renmin University of China. “A cross-sector approach to active ageing – which touches all aspects of our lives from the cities we live in to the places we work and how we care for ourselves and participate in our communities as we age – will be essential for our success.”

The summit will place emphasis on skin health as a critical component of wellness and prevention, which serves as a model for how healthy and active ageing can be achieved. It and other conditions associated with ageing should be considered in a broader approach to healthy ageing.

“Our skin is our largest organ, which protects us from external harms and defends against disease and infection,” said Peter Nicholson, Vice President of Business Development & Strategy for Nestlé Skin Health.  “Since we are living longer, our skin must protect us for longer, with impacts on our physical health, mental health, and ability to engage socially. A life course of healthy skin is as important for today’s young to age well as it is for a more active and healthier ageing for today’s older demographic.”

One in two people over the age of 65 suffers from intense dryness of the skin, which can lead to infection and wounds. Further, skin conditions and diseases are often related to non-communicable diseases like cancers and diabetes, which increase in prevalence with age. In addition to the physical effects and medical care and costs associated with conditions of fragile skin, there are emotional and social implications as well, which can impact one’s ability to maintain independence and negatively impact quality of life.

As a result of the high-level commitment to the “Life Course of Healthy Skin Partnership,” Nestlé Skin Health announced its plan to open a global network of SHIELD (Skin Health Investigation, Education and Longevity Development) centers to meet skin health challenges that result from 21st century longevity. The network is built to foster breakthroughs and collaboration in skin health through medical investigation, education and applications related to the convergence of technologies and bio-informatics. The first SHIELD center will be in New York City, and the second will open in Shanghai in the first quarter of 2016 with 10 other locations planned in the future. The Shanghai SHIELD center was announced in partnership with the Global Coalition on Aging on 21 July with a ceremony hosted by Nestlé Skin Health CEO Humberto Antunes.

Collaborative partnerships achieved during the Shenyang Summit will continue to further the overarching goal of ageing as an opportunity for economic growth and stability. Insights and best practices shared throughout the event will be leveraged on a global scale and utilized to mobilize international leaders to act on reinventing how we age.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.